Table 2.
Multivariate analysis demonstrating the independent risk factor for the cancer-specific death of the patients with gastric cancer (n = 84)
The correlation between clinicopathologic characteristics and CD39 expression | |||||||
---|---|---|---|---|---|---|---|
| |||||||
Characteristics | tCD39 | pCD39 | |||||
|
|
||||||
low | high | P value | low | high | P value | ||
Age | ≤60 | 9 | 33 | 1.000 | 18 | 24 | 1.000 |
>60 | 9 | 33 | 17 | 25 | |||
Gender | male | 15 | 39 | 0.094 | 19 | 35 | 0.114 |
female | 3 | 27 | 16 | 14 | |||
Tumor size | ≤3 cm | 10 | 39 | 0.794 | 24 | 25 | 0.122 |
>3 cm | 8 | 27 | 11 | 24 | |||
Histology | good | 9 | 28 | 0.601 | 14 | 23 | 0.656 |
poor | 9 | 38 | 21 | 26 | |||
Lanren | intestinal | 14 | 45 | 0.565 | 22 | 37 | 0.234 |
diffuse | 4 | 21 | 13 | 12 | |||
Tumor differentiation | I | 0 | 2 | 0.495 | 0 | 2 | 0.285 |
II | 8 | 23 | 12 | 19 | |||
III | 10 | 41 | 23 | 28 | |||
Survival | yes | 17 | 45 | 0.032 | 24 | 38 | 0.431 |
no | 1 | 21 | 11 | 11 |